InsiderClue
Insiders · Profile

PRESTRELSKI STEVEN

Chief Scientific Officer at Xeris Biopharma. Filing since 22 Feb 2022. CIK 0001744027

Company
Date
Role
Action
Shares
Amount
Of holding
XERS Xeris Biopharma Holdings, Inc.
22 Feb 2022
Chief Scientific Officer
Sold, plan not stated
11,228
$27.16K
1.9%
1 decision on file.